Overview

Definition:
-Oncoplastic therapeutic reduction is a surgical approach that combines oncological resection of breast cancer with simultaneous breast reduction techniques
-It aims to achieve negative surgical margins while also addressing macromastia or asymmetry, thereby improving aesthetic outcomes and patient satisfaction compared to traditional lumpectomy alone, especially in patients desiring smaller breasts or symmetry.
Epidemiology:
-Macromastia affects a significant percentage of women, leading to symptoms like neck/back pain and functional impairment
-The incidence of breast cancer in women with macromastia requiring oncoplastic reduction varies but is an important consideration in breast cancer management
-It is particularly relevant for women diagnosed with large breast tumors relative to breast size, where simple lumpectomy might lead to significant deformity.
Clinical Significance:
-This technique offers a crucial solution for breast cancer patients who have macromastia or significant breast asymmetry
-It allows for oncological safety with wide local excision and immediate aesthetic restoration, avoiding the disfigurement often associated with large tumor excisions in small breasts
-It enhances quality of life by resolving macromastia-related symptoms and providing a more pleasing cosmetic result, which can positively impact psychosocial well-being post-treatment.

Indications

Indications For Procedure:
-Breast cancer with macromastia requiring significant tissue removal
-Large breast tumors where simple lumpectomy would result in unacceptable cosmetic deformity
-Patients desiring breast reduction for symptomatic relief or aesthetic reasons who also have breast cancer
-Significant breast asymmetry requiring reduction of the contralateral breast for symmetry
-Multicentric or diffuse multifocal disease suitable for conservative management but with resulting deformity.
Contraindications:
-Inability to achieve clear margins with conservative resection
-Locally advanced breast cancer requiring mastectomy
-Active infection or inflammation of the breast
-Severe comorbidities that preclude major surgery
-Patient refusal of oncoplastic approach or preference for mastectomy.
Patient Selection Criteria:
-Good overall health
-Realistic expectations regarding outcomes
-Willingness for follow-up
-Tumor amenable to conservative resection with oncological safety
-Presence of macromastia or significant asymmetry that would benefit from reduction
-Adequate breast tissue volume to allow for reduction and reconstruction.

Preoperative Preparation

Informed Consent:
-Detailed discussion of risks, benefits, alternatives, expected outcomes, need for potential future procedures, and oncological safety
-Emphasis on the dual nature of the surgery: cancer removal and aesthetic shaping.
Imaging And Staging:
-Standard breast cancer workup including mammography, ultrasound, MRI (if indicated), and biopsy
-Staging investigations as per protocol (e.g., chest X-ray, abdominal ultrasound, bone scan, CT scan if indicated).
Markings:
-Careful preoperative marking of the tumor, planned excision lines, breast mound reshaping, nipple-areolar complex position, and planned reduction pattern (e.g., Wise pattern, vertical scar, inferior pedicle)
-Markings should facilitate a oncoplastic surgeon's approach.
Anesthesia Considerations:
-General anesthesia is typically required
-Multimodal analgesia strategies for postoperative pain control
-Consideration of tumescent infiltration for hemostasis and postoperative pain management.
Surgical Planning:
-Selection of appropriate oncoplastic technique based on tumor location, size, breast volume, and surgeon's expertise
-Consideration of pedicle design for nipple-areolar complex viability if preserved
-Planning for contralateral symmetrization surgery, which may be done simultaneously or in a staged fashion.

Procedure Steps

Oncological Excision:
-Wide local excision of the tumor with a clear margin of at least 1 cm of normal breast tissue
-Specimens should be oriented for pathological assessment of margins
-In some cases, intraoperative margin assessment may be considered.
Breast Reshaping And Reduction:
-Utilizing standard breast reduction techniques (e.g., superior pedicle, inferior pedicle, central mound) to sculpt the remaining breast tissue
-Tissue is mobilized, de-epithelialized where necessary, and repositioned to achieve the desired contour and volume
-Preservation of adequate vascularity to the remaining breast tissue and pedicle is paramount.
Nipple Areolar Complex Management:
-Depending on tumor location and size, the NAC may be preserved, partially resected, or sacrificed
-If preserved, it is typically transposed on a vascularized pedicle
-For central tumors or those involving the NAC, mastectomy with immediate reconstruction or NAC resection may be necessary.
Closure And Drainage:
-Meticulous layered closure of subcutaneous tissue and skin
-Placement of surgical drains to manage seroma formation
-Drains are typically removed when output is minimal.
Contralateral Symmetrization:
-Often performed simultaneously to achieve symmetry
-This involves performing a similar reduction mammoplasty on the contralateral breast to match the volume and shape of the reconstructed breast
-Alternatively, it can be done as a delayed procedure.

Postoperative Care

Monitoring:
-Close monitoring of vital signs, flap viability, and for signs of infection or hematoma
-Assessment of drain output
-Pain management is crucial.
Dressing And Support:
-Application of a surgical bra or supportive dressing to minimize swelling and provide support to the reconstructed breast
-Dressing changes as per protocol.
Drain Management:
-Monitoring drain output and timing of removal
-Educating the patient on drain care if discharged with drains.
Activity Restrictions:
-Guidance on limitations of arm movement and physical activity to protect the surgical site and allow for healing
-Gradual return to normal activities over several weeks.
Medications:
-Analgesics for pain control
-Prophylactic antibiotics may be considered
-Anticoagulation may be necessary for high-risk patients.

Complications

Early Complications:
-Hematoma
-Seroma
-Wound infection
-Skin necrosis (especially of the nipple-areolar complex or flap edges)
-Partial or complete flap dehiscence
-Asymmetry
-Nerve injury leading to altered sensation.
Late Complications:
-Chronic pain
-Scar hypertrophy or keloid formation
-Fat necrosis
-Implant-related complications (if used in subsequent reconstruction)
-Persistent asymmetry
-Poor aesthetic outcome
-Lymphedema
-Recurrence of cancer.
Prevention Strategies:
-Meticulous surgical technique, careful flap design and preservation of vascularity, judicious use of drains, adequate hemostasis, appropriate antibiotic prophylaxis, patient education on wound care and activity, and careful patient selection
-Early recognition and management of complications are key.

Prognosis

Factors Affecting Prognosis:
-Stage of breast cancer at diagnosis
-Histological subtype and grade
-Receptor status (ER, PR, HER2)
-Adequacy of surgical margins
-Patient's overall health and adherence to adjuvant therapies
-Surgeon's experience.
Outcomes:
-Excellent oncological outcomes are achievable with adequate margins
-Good to excellent aesthetic outcomes are reported, with high patient satisfaction rates
-Reduction in macromastia-related symptoms
-Improved body image and psychosocial well-being.
Follow Up:
-Regular follow-up appointments are essential for monitoring the surgical site for complications, assessing aesthetic outcomes, and surveillance for breast cancer recurrence
-Surveillance protocols should follow established breast cancer guidelines, including regular clinical breast examinations and appropriate imaging (mammography, MRI as indicated).

Key Points

Exam Focus:
-Understanding the principles of oncoplastic surgery
-Indications and contraindications for therapeutic reduction
-Key surgical techniques and pedicle designs
-Management of nipple-areolar complex
-Common complications and their management
-Differentiating from standard lumpectomy and mastectomy
-Importance of oncological safety alongside aesthetic outcomes.
Clinical Pearls:
-Always prioritize oncological safety
-achieve clear margins first
-Consider contralateral symmetrization early in the planning process
-Meticulous technique for flap viability is critical
-Patient selection and realistic expectations are paramount for satisfaction
-Communication between surgeon, oncologist, and pathologist is vital.
Common Mistakes:
-Inadequate margin clearance
-Compromising vascularity to flaps
-Poor planning of nipple-areolar complex transposition
-Underestimating tissue redundancy in macromastia
-Neglecting contralateral symmetrization leading to significant asymmetry
-Failing to adequately counsel patients on potential complications and long-term follow-up.